Oct 16, 2026 06:56AM
Oct 13, 2026 06:47AM
Oct 7, 2026 06:49AM
Sep 3, 2026 06:58AM
Aug 18, 2026 06:38AM
Aug 7, 2026 07:32AM
Aug 7, 2026 07:02AM Leerink Upgrades Halozyme Therapeutics (HALO) to Outperform
Aug 6, 2026 04:30PM
Jul 21, 2026 09:23AM
Jun 16, 2026 06:43AM
Jun 15, 2026 06:01AM
Jun 3, 2026 09:02AM
May 13, 2026 05:40AM
May 12, 2026 05:47AM Halozyme Therapeutics (HALO) Reiterated at Market Outperform by Citizens on Beating Q1 Estimates
May 11, 2026 04:20PM
May 11, 2026 04:03PM
Apr 29, 2026 06:59AM
Apr 13, 2026 08:39AM
Apr 7, 2026 11:08AM
Apr 7, 2026 08:05AM
Feb 19, 2026 10:25AM Halozyme Therapeutics (HALO) PT Raised to $90 at Benchmark Following Strong Q4 Results
Feb 18, 2026 08:14AM
Feb 17, 2026 04:06PM
Feb 3, 2026 09:29AM
Jan 29, 2026 06:49AM
Jan 29, 2026 04:44AM
Jan 28, 2026 06:41AM
Jan 8, 2026 09:30AM Halozyme Therapeutics (HALO) PT Raised at TD Cowen; 'One of Our Top Picks for 2026'
Dec 5, 2025 05:18AM
Dec 4, 2025 01:28PM
Dec 4, 2025 06:51AM
Nov 28, 2025 06:34AM
Nov 17, 2025 11:21AM
Nov 7, 2025 08:31AM
Nov 4, 2025 05:03AM Halozyme Therapeutics (HALO) PT Raised to $92 at Citizens on Strong Quarter
Nov 3, 2025 04:02PM
Oct 21, 2025 06:46AM
Oct 14, 2025 01:26PM
Oct 2, 2025 06:42AM
Oct 2, 2025 04:28AM
Oct 1, 2025 01:20PM
Oct 1, 2025 01:13PM FDA on Operations During Shutdown: 'FDA will not be able to accept any regulatory submissions for FY 2026 that require a fee payment'
Oct 1, 2025 04:21AM
Sep 24, 2025 08:20AM
Sep 22, 2025 06:42AM
Aug 12, 2025 04:59AM
Aug 6, 2025 04:08AM
Aug 6, 2025 03:37AM
Aug 5, 2025 04:05PM Halozyme Therapeutics (HALO) Tops Q2 EPS by 30c ; Offers Guidance
Jul 23, 2025 11:39AM

479,031 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All